Injection device with non-fixed gas cylinder and drive system for injection device
By nesting a gas canister inside the plunger, the problems of large size and high noise in existing injection devices are solved, achieving compact and stable drug delivery and improving the user experience.
Patent Information
- Application Number
- CN202580029658.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-03-16
- Filing Date
- 2025-03-16
- Publication Date
- 2026-11-17
AI Technical Summary
Existing automated injection devices suffer from problems such as large size, high noise, unstable injection force, and potential pain for patients. In particular, the gas cylinder in gas-powered injection devices occupies a large space, making it difficult to shorten the device length.
The design employs a gas canister nested within the plunger. Pressurized gas is released through an opening mechanism to propel the plunger and deliver the drug. The plunger and gas canister together shorten the length of the drive module, providing a more compact injection device.
It achieves a more compact injection device design, reduces the risk of noise and pain, provides stable drug delivery force, and improves the user experience.
Smart Images

Figure CN123125004A_ABST
Abstract
Description
Relevant application data
[0001] This application claims the benefit of co-pending U.S. Provisional Application Serial No. 63 / 566,233, filed March 16, 2024, the entire disclosure of which is expressly incorporated herein by reference. Technical Field
[0002] This application relates throughout to apparatus and methods for delivering pharmaceutical agents into a subject, and more specifically to automated injection devices and / or gas-powered drive systems for injection devices, as well as methods for manufacturing and using such devices. Background Technology
[0003] Many applications involve delivering medications or other agents to a patient subcutaneously, intramuscularly, or otherwise. For example, automated infusion devices containing a predetermined dose of medication can be used, which can be automatically delivered to the patient, for instance, upon placement close to the patient's skin and activation. Manual infusion devices are also available, allowing the user to manually deliver the desired dose of medication.
[0004] Generally, automated injection devices are spring-loaded syringes that release a spring upon activation, generating sufficient force to pierce the skin with the needle and deliver the dose within the syringe. For viscous fluids, the force required to generate the fluid flow may exceed what the spring-powered system can provide. When springs are used, they must generate relatively large forces, requiring springs with significant mass. Consequently, such automated injection devices can generate considerable noise, pressure spikes in the syringe, potentially causing glass breakage, vibration, and / or forcibly driving the needle into the patient's skin, which can cause pain and / or startle the user, especially when the patient is self-injecting.
[0005] Pneumatically powered automated injection devices have also been developed, such as those disclosed in U.S. Patents 10,716,892, 10,912,883, and 11,071,824, the entire disclosure of which is expressly incorporated herein by reference. A pneumatically powered injection device includes a gas canister or container within it, filled with pressurized gas used to power a plunger or other force-providing component to deliver one or more agents from the injection device. The gas canister can occupy a significant amount of space, especially when coaxially positioned and fixed in the direction of injection and connected in series with another force-providing component (e.g., a plunger). The length of the plunger and its displacement distance, as well as the length of the gas canister located proximal to the plunger, determine the minimum length of the injection device, making shortening the length of the injection device challenging, if not impossible.
[0006] Therefore, improved devices and methods for delivering drugs into patients (e.g., devices and methods that are more compact than conventional injection devices) would be useful. Summary of the Invention
[0007] This application relates generally to apparatus and methods for delivering a drug agent into a subject, and more specifically to injection devices and / or pneumatically driven systems for injection devices, such as injection devices and / or pneumatically driven systems that are more compact than conventional injection devices. For example, the plunger or other force-providing component of the injection device is typically the longest component in the drive module, and nesting a gas canister and / or its opening mechanism within the plunger, or providing an elongated gas canister instead of a conventional plunger, can shorten the length of the drive module and provide a more compact injection device.
[0008] According to one example, a drive module is provided for delivering one or more medications from an injection device module into a patient, the injection device module including a medication chamber containing one or more medications, an outlet, and a piston. The drive module includes: a drive housing including a first end and a second end, and a first chamber located within the drive housing; a plunger including a proximal end disposed within the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger being configured to engage with a piston of the injection device module; a canister at least partially received within the plunger such that the canister follows movement of the plunger, the canister containing pressurized gas and including an outlet; an opening mechanism located within the drive housing adjacent to the first end and including an actuating pin disposed adjacent to the outlet; and an actuator configured to move one of the opening mechanism and the canister to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger and the canister, the plunger being configured to advance the piston of the injection device module to deliver one or more medications from the medication chamber through the outlet.
[0009] According to another example, an apparatus for delivering one or more pharmaceutical agents into a patient is provided, the apparatus including an injection device module comprising an injection device housing and a piston, the injection device housing carrying a pharmaceutical chamber containing one or more pharmaceutical agents, the piston being slidably disposed within the pharmaceutical chamber. The device also includes a drive module comprising: a drive housing including a first end and a second end, and a first chamber located within the drive housing; a plunger including a proximal end disposed within the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing and is coupled to a piston of an injection device module; a canister at least partially received within the plunger such that the canister follows the movement of the plunger, the canister containing pressurized gas and including an outlet; an opening mechanism located within the drive housing adjacent to the first end and including an actuating pin disposed adjacent to the outlet; and an actuator configured to move one of the opening mechanism and the canister to open the outlet and allow gas in the canister to flow into the first chamber to advance the plunger and the canister, wherein the plunger advances the piston of the injection device module to deliver one or more medications from a medication chamber through the outlet.
[0010] According to yet another example, a drive module is provided for delivering one or more medications from an injection device module into a patient, the injection device module including a medication chamber containing one or more medications, an outlet, and a piston. The drive module includes: a drive housing including a first end and a second end, and a first chamber located within the drive housing; a plunger including a proximal end disposed within the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger being configured to engage with a piston of the injection device module; a plunger chamber located within the plunger and containing pressurized gas and including an outlet adjacent to the proximal end; an opening mechanism located within the drive housing and including an actuating pin disposed adjacent to the outlet; and an actuator configured to move one of the opening mechanism and the canister to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger, the plunger being configured to advance the piston of the injection device module to deliver one or more medications from the medication chamber.
[0011] According to yet another example, an apparatus is provided for delivering one or more pharmaceutical agents into a patient, the apparatus comprising: an injection device module including an injection device housing and a piston, the injection device housing carrying a pharmaceutical chamber containing one or more pharmaceutical agents, the piston being slidably disposed within the pharmaceutical chamber; and a drive module. The drive module includes: a drive housing having a first end and a second end, and a first chamber located within the drive housing; a plunger having a proximal end disposed within the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing and is coupled to a piston of the injection device module; a plunger chamber located within the plunger and containing pressurized gas and including an outlet adjacent to the proximal end; an opening mechanism located within the drive housing and including an actuating pin disposed adjacent to the outlet; and an actuator configured to move one of the opening mechanism and the canister to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger, the plunger being configured to advance the piston of the injection device module to deliver one or more medications from a medication chamber.
[0012] Any injection device described herein may include any actuator disclosed in the patents incorporated herein by reference. For example, an actuating sleeve may be provided that retracts when the needle is inserted into the patient's skin, thereby activating an opening mechanism to release gas. Alternatively, a screw, lever, button, or other actuator may be provided on the drive module that can be manually activated by the user to actuate the opening mechanism to release gas.
[0013] Other aspects and features of the invention will become apparent from the following description taken in conjunction with the accompanying drawings. Attached Figure Description
[0014] It will be believed that the invention will be better understood through the following description of certain examples taken in conjunction with the accompanying drawings, wherein like reference numerals identify like elements, and in the drawings: Figure 1 This is a perspective view of an exemplary automatic injection device, which includes a front housing, a rear housing, and a safety cap.
[0015] Figures 2A and 2B are longitudinal cross-sections of an exemplary automated injection device, showing the internal components of the device (including a syringe carrying one or more medications).
[0016] Figure 3A and Figure 3B The details of the distal end of the device in Figures 2A and 2B before use are shown, including the start-up cap of the covering device and the safety cap of the needle.
[0017] Figures 4A-4CThe figures 2A and 2B are cross-sections of the devices, showing the activation of the device when the device is pressed against the subject's skin to puncture the skin with a needle. The activation cap moves proximally, causing the spacer and release cap to also move proximally to release the carriage carrying the opening pin, which then moves distally to open the gas canister, thereby releasing pressurized gas into the flow path within the device.
[0018] Figures 5A-5C They are as follows Figures 4A-4C Details of the proximal end of the device shown.
[0019] Figure 6A and Figure 6B The device shown in Figures 2A and 2B is in cross-section after the pressurized gas has been released, illustrating the plunger within the pressurized gas propulsion device for delivering one or more medications in the syringe through a needle, and the propulsion cap being pushed when the needle is withdrawn from the subject's skin.
[0020] Figure 6C yes Figure 6B The details of the device shown illustrate the tabs that lock the starter cap after it is pushed in.
[0021] Figure 7A It is an injection device (such as) Figure 1 - A schematic cross-sectional view of the injection device shown in Figure 6, which includes a fixed gas canister adjacent to the plunger and an opening mechanism, the plunger being displaced by pressurized gas from the gas canister to advance the syringe piston to deliver a drug from the syringe.
[0022] Figure 7B This is a cross-sectional schematic diagram of another injection device, which includes a gas cylinder adjacent to a plunger that is displaced by pressurized gas to advance a syringe piston for delivering medication from the syringe.
[0023] Figure 8A and Figure 8B This is a cross-sectional schematic diagram of an injection device, which includes a gas canister nested within a plunger and an opening mechanism, showing the plunger in its initial position. Figure 8A ) and its extended position ( Figure 8B ).
[0024] Figure 9A and Figure 9B This is a cross-sectional schematic diagram of another injection device, which includes a gas canister integrated with the plunger, showing the plunger in its initial position. Figure 9A ) and its extended position ( Figure 9B ).
[0025] The accompanying drawings are not intended to be limiting in any way, and various examples of the invention are contemplated that they may be implemented in many other ways, including those not necessarily depicted in the drawings. The drawings, which are incorporated in and constitute a part of this specification, illustrate aspects of the invention and, together with the description, explain the principles of the invention; however, it should be understood that the invention is not limited to the precise arrangements shown. Detailed Implementation
[0026] Before describing the examples, it should be understood that the invention is not limited to the specific examples described, as these examples can certainly vary. It should also be understood that the terminology used herein is for the purpose of describing specific examples only and is not intended to be limiting, as the scope of the invention is limited only by the appended claims.
[0027] Where a numerical range is provided, it should be understood that intermediate values between the upper and lower limits of that range are also explicitly disclosed, wherein the lower limit is accurate to the tenths place unless the context otherwise expressly specifies. Each smaller range between any stated value or intermediate value in the range and any other stated value or intermediate value in the range is covered within the invention. The upper or lower limit of these smaller ranges may be independently included or excluded from the range, and each range including any limit, no limit, or both limits is also covered within the invention and is subject to any explicitly excluded limit in the range. When an explicit range includes one or both of the limits, ranges excluding one or both of those included limits are also included in the invention.
[0028] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although any methods and materials similar to or equivalent to those described herein may be used in the practice or testing of this invention, some potential and exemplary methods and materials are now described.
[0029] It must be noted that, as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural objects unless the context clearly indicates otherwise. Thus, for example, reference to “compound” includes a plurality of such compounds, and reference to “polymer” includes reference to one or more polymers and their equivalents known to those skilled in the art, etc.
[0030] This document uses numerical values preceded by the term "approximately" to present certain ranges. The term "approximately" provides textual support for precise figures that follow it, as well as for figures that are close to or approximate to those following terms. In determining whether a number is close to or approximates an exact listed number, a number that is close to or approximates an unlisted number may be a number that provides approximately equal value to the exact listed number in the context in which it is presented.
[0031] Switch to the attached image. Figure 1 An example of an automated injection device 6 is shown, comprising a housing 8 including a front housing 10 and a rear housing 12. The front housing carries a syringe 70 containing one or more medications within a medication chamber. The rear housing includes a drive assembly for automatically delivering medications from the syringe 70 when the device 6 is activated. As shown, a safety cap 86 is disposed on the front housing 10 to prevent premature activation of the device 6; this safety cap can be removed immediately before injection, as further described elsewhere herein. When the device 6 is activated, one or more internal components of the device 6 are axially movable relative to the longitudinal axis 18, i.e., proximal and / or distal, as further described elsewhere herein.
[0032] In one example, syringe 70 may be a pre-filled syringe, for example, made of glass, plastic, etc., which is filled with a predetermined volume of medication for a single dose to a patient. Alternatively, if desired (not shown), the medication chamber and needle may be integrated into the front housing 10. In another alternative, syringe 70 (or integral medication chamber) may include a needleless distal port (not shown), such that a separate needle (also not shown) may be coupled to the port, for example, immediately before injection, using a Luer connector, mating thread, and / or other mating fasteners, or otherwise as required. As used herein, "medication" may include one or more flowable therapeutic and / or diagnostic compounds, drugs, or materials, in, for example, liquid or gaseous form, solution or suspension, such as viscous fluids.
[0033] Turning to Figures 2A and 2B, an exemplary automated injection device 6 is shown, comprising a housing 8 including a front housing 10 and a rear housing 12. The front housing carries a syringe 70 containing one or more medications within a medication chamber 73. The rear housing includes a drive assembly for automatically delivering medication from the syringe 70 when the device 6 is activated. As shown, a safety cap 86 is disposed on the front housing 10 to prevent premature activation of the device 6; this safety cap can be removed immediately before injection, as further described elsewhere herein. When the device 6 is activated, one or more internal components of the device 6 are axially movable relative to the longitudinal axis 18, i.e., proximal and / or distal, as further described elsewhere herein.
[0034] In one example, syringe 70 may be a pre-filled syringe, for example, made of glass, plastic, etc., which is filled with a predetermined volume of medication for a single dose to a patient. Alternatively, if desired (not shown), the medication chamber and needle may be integrated into the front housing 10. In another alternative, syringe 70 (or integral medication chamber) may include a needleless distal port (not shown), such that a separate needle (also not shown) may be coupled to the port, for example, immediately before injection, using a Luer connector, mating thread, and / or other mating fasteners, or otherwise as required. As used herein, "medication" may include one or more flowable therapeutic and / or diagnostic compounds, drugs, or materials, in, for example, liquid or gaseous form, solution or suspension, such as viscous fluids.
[0035] Referring again to Figures 2A and 2B, the syringe 70 includes a syringe 72 containing a drug within a drug chamber 73, a needle 78 extending from a distal end 72a of the syringe 72, and a piston or stopper 74 slidable within a proximal end 72b of the syringe 72 for guiding the drug through the needle 78 into a subject (not shown). The device 6 also includes a gas canister or other pressurized gas source 40 to power the device 6, for example, by advancing a plunger 50 coupled to the piston 74 to deliver the drug. The device 6 also includes an activation cap 80 and an opening mechanism 60 for opening the canister 40 to release pressurized gas within the canister 40 into a set of chambers of the device 6. For example, an inner housing 20 may be mounted within an outer housing 8, the inner housing including, for example, a first chamber or proximal chamber 22 in which the gas canister 40 is housed, and a second chamber or distal chamber 24 in which, for example, the plunger 50 is slidably received.
[0036] Typically, the device 6 is configured such that when the contact surface 84 of the activation cap 80 is pressed against the subject's skin to insert the needle 78, the activation cap 80 retracts proximally into the housing 8 and automatically activates the opening mechanism 60 to release pressurized gas from the canister 40 into the first chamber 22 and the second chamber 24. This generates a distal force to advance the plunger 50, thereby delivering the medication from the syringe 70 to the subject. After the injection is completed and the device 6 is withdrawn from the skin, the activation cap 80 can automatically advance to cover the needle 78.
[0037] For example, a spacer 30 may be provided extending between the activation cap 80 and the release cap 34 of the opening mechanism 60, such that proximal movement of the activation cap 80 is transmitted by the spacer 30 to guide the release cap 34 proximally within the rear housing 12, which releases the spring seat assembly or carriage 64 of the opening mechanism 60, as further described elsewhere herein. The spacer 30 may be distally biased, for example, by a spring 32, which in turn may distally bias the activation cap 80 after injection is complete, also as further described elsewhere herein.
[0038] Typically, the housing 8 includes a proximal end 8a (e.g., disposed on the rear housing 12), an open distal end 8b (e.g., disposed on the front housing 10), and an inner wall extending between the two to enclose the interior of the device 6. The dimensions and / or shape of the outer surface between the proximal end 8a and the distal end 8b may be designed to facilitate manipulation of the device 6, for example, to facilitate placing and pressing the activation cap 80 against the subject's skin to activate the device 6 and inject a drug. For example, the outer surface may have a generally cylindrical shape and optionally include one or more textures or gripping features to facilitate an operator (the subject or a third party) holding the device 6 with one hand and pressing the activation cap 80 against the subject's skin, as further described elsewhere herein. As shown, the proximal end 8a of the housing 8 may include a wall 8c closing the proximal end 8a, and optionally one or more recesses or other features 8d for locking the release cap 34, as further described elsewhere herein.
[0039] The outer shell 8 may be formed from multiple individual components (e.g., clamshell halves), such as metals (e.g., stainless steel, aluminum, etc.), plastics, and / or composite materials, formed by one or more of cold drawing, molding, casting, machining, etc., and these components are substantially fixedly attached together, for example, by one or more of welding, brazing, fusion, adhesive bonding, interference fit, etc. As shown, the outer shell 8 is formed as separate front shell 10 and rear shell 12, which can be assembled separately with corresponding internal components and then joined together, for example, after the syringe 70 is loaded into the front shell 10.
[0040] For example, during manufacturing, the front housing 10 may be assembled with the starter cap 80 and the safety cap 86, and the syringe 70 may be loaded into the interior of the front housing 10 at any time before injection, such as during manufacturing or assembly of the device 6. Optionally, as Figure 3A and Figure 3B As shown, the syringe 70 may include, for example, a rigid needle guard 79 formed of a conventional material, which is removably secured to the distal end 72a of the syringe barrel 72 to protect the needle and prevent accidental punctures. The safety cap 86 may include features 86a that engage with the needle guard 79 such that when the safety cap 86 is removed, the needle guard 79 is also removed. For example, as shown, the proximal end of the safety cap 86 may include one or more fingers 86a that, when the syringe 70 is inserted into the front housing 10, fall into one or more corresponding cuts, recesses, or other features on the needle guard 79, thereby attaching the needle guard 79 to the safety cap 86, as described elsewhere herein.
[0041] The rear housing 12 can be assembled with the inner housing 20, spacer 30, release cap 34, gas canister 40, plunger 50, and opening mechanism 60 (and any other incidental components), and the rear housing 12 can be coupled to the front housing 10 at any time. For example, during manufacturing, the syringe 70 can be loaded into the interior of the front housing 10, and the assembled rear housing 12 can be immediately coupled to the front housing 10. When the rear housing 12 is attached to the front housing 10, the distal end 54 of the plunger 50 can be coupled to the piston 74 within the syringe 70, for example, such that distal movement of the plunger 50 is transmitted to the piston 74, as further described elsewhere herein.
[0042] As shown in Figures 2A and 2B, the housing 8 may include, for example, a mounting member 11 on one of the front housing 10 and the rear housing 12 for guiding and / or securing the syringe 70 during loading. Optionally, the proximal end 72b of the syringe 72 may include one or more flanges (e.g., radial flanges or a pair of opposing flanges) that abut against and / or are received therein with the mounting member 11 to secure the syringe 70 relative to the front housing 10. Additionally or alternatively, one or more notches, ridges, or other features (not shown) may be provided on the front housing 10 for securing the syringe 70. Optionally, the front housing 10 may include one or more windows 10c in its sidewalls, which facilitates observation of the syringe 70 during injection, such as allowing visual confirmation when the piston 74 is fully advanced.
[0043] Optionally, the device 6 may include a syringe spacer or adapter 75 that provides an interface between the distal end 54 of the plunger 50 and the piston 74, for example, to provide a connection between the two and / or ensure proper spacing so that the piston 74 advances together with the plunger 50. For example, spacers 75 of different lengths may be provided to allow syringes of different lengths to be loaded into the front housing 10 while properly positioning the needle 78 near the distal end 8b of the housing 8 and allowing the plunger 50 to be properly coupled to the piston 74.
[0044] During manufacturing or assembly, a syringe 70 may be optionally inserted into the housing 8, for example, through an opening in the distal end 8b, and coupled to the distal end 16 of the drive assembly 12. A syringe spacer 75 may be optionally inserted, and its distal end 75a may be coupled to the piston 74, for example, through one or more mating threads (as shown), one or more recesses, or other connecting elements. When the rear housing 12 is coupled to the front housing 10, the distal end 54 of the plunger 50 may be inserted into a recess 75b in the syringe spacer 75. Optionally, the distal end 54 of the plunger 50 and the recess 75b may include mating locking features, such as one or more threads, recesses, etc. (not shown), or the distal end 54 may simply be inserted into the recess 75b to engage subsequent distal movement of the piston 74 to the plunger 50, as further described elsewhere herein.
[0045] Alternatively, the assembled housings 10, 12 may be packaged, stored, and / or otherwise prepared for subsequent assembly. For example, the housings 10, 12 may be transported or otherwise provided to the manufacturer of the syringe 70, who may load the syringe 70 and assemble the housings 10, 12 together to provide the finished device 6. In another alternative, the assembled housings 10, 12 may be provided to hospitals, physicians, or other medical professionals, and final assembly may be completed immediately prior to injection, allowing for the loading of a syringe containing a specific medication before injection.
[0046] The proximal end 10a of the front housing 10 and the distal end 12b of the rear housing 12 may include one or more mating connectors (not shown) to join the housings 10, 12 together, thereby providing a fully assembled device 6. For example, the housings 10, 12 may include one or more mating threads, notches, etc., which can securely join the housings 10, 12 together. Alternatively, the connectors may allow the housings 10, 12 to be subsequently separated (e.g., after injection) to remove the syringe 70, for example to allow the device 6 to be cleaned and reused with a new syringe.
[0047] Alternatively, the housings 10 and 12 may be securely attached together by one or more of the following methods: interference fit between ends 10a and 12b, adhesive bonding, fusion, acoustic welding, etc. In another alternative, the outer housing 8 may be formed as a single integral component into which components of the device 6 can be assembled. In these alternatives, or even in the case of a two-part housing, the device 6 may be a disposable device that can be discarded after a single injection.
[0048] In the examples shown in Figures 2A and 2B, the inner housing 20 includes a proximal cylindrical body 20a having a first chamber 22 and a distal cylindrical body 20b having a second chamber 24. Each of the proximal cylindrical body 20a and the distal cylindrical body 20b may have an elongated cylindrical wall or other cross-sectional shape along its length. The proximal cylindrical body 20a and the distal cylindrical body 20b may be securely attached together, for example, by one or more of mating threads (as shown), notches or other fasteners, press fits, adhesive bonding, acoustic welding, fusion, etc., to provide the inner housing 20. Alternatively, the inner housing 20 may be formed as a single integral structure including the first chamber 22 and the second chamber 24. The proximal cylindrical body 20a and the distal cylindrical body 20b may be formed of a material similar to or different from the outer housing 8.
[0049] The inner housing 20 may be installed within the outer housing 8 such that the inner housing 20 remains substantially fixed within the outer housing 8. Similarly, the gas cylinder 40 may be installed within the inner housing 20, for example within the first chamber 22, such that the gas cylinder 40 also remains substantially fixed relative to the outer housing 8. For example, one or more pillars, supports, or other structures (not shown) may be provided on the inner housing 20 and / or the outer housing 8 to secure the inner housing 20 and / or the gas cylinder 40 relative to the outer housing 8.
[0050] In the example shown, the proximal barrel 20a may include an annular wall surrounding the first chamber 22, the annular wall including a first region 22a of uniform diameter in which the gas canister 40 is mounted, and a second region 22b and a third region 22c in which the carriage 64 is slidably mounted, as further described elsewhere herein. The distal barrel 20b may have a length such that when the device 6 is assembled, the distal end 21b of the distal barrel 20b can abut against the syringe 70.
[0051] Optionally, the distal end 21b may include one or more features that contact the proximal end 72b of the syringe 70, such as an O-ring 20d formed of an elastic and / or relatively flexible material and fixed to or around the distal end 21b. The O-ring 20d can prevent the distal end 21b from damaging the syringe 70, for example, in the case where the syringe 72 is made of glass.
[0052] Referring again to Figures 2A and 2B, the canister 40 includes a body 42 comprising a first closed end 42a, a second outlet end 42b, and a cap 44 welded or otherwise attached to the outlet end 42b to provide a closed cavity 48 filled with a fluid containing a pressurized gas (such as carbon dioxide or fluorocarbon gas) compressed to a sufficient pressure to at least partially liquefy the gas within the cavity 48. Alternatively, a fluid containing a gas such as argon, nitrogen, helium-argon, or other combinations thereof retained in gaseous form may be stored within the cavity 48. As described elsewhere herein, the pressurized fluid contained within the cavity 48 may be used to generate force to operate the device 6, for example, to inject one or more pharmaceutical agents from the syringe 70 into a subject.
[0053] In one example, the body 42 and the cap 44 may be formed of stainless steel or other desired or suitable metals, plastics, or composite materials, for example by drawing, stamping, machining, casting, molding, etc. For example, the body 42 may be deep drawn from a sheet of metal (e.g., a circular sheet blank of type 305 stainless steel) using one or more dies and punches (not shown) to form a main syringe region, a closed end 42a, an optional tapered shoulder region, and an outlet end 42b defining an opening for attachment of the cap 44.
[0054] As shown, can 40 may be oriented such that outlet end 42b is located proximal to closed end 42a, and carriage 64 may be disposed proximal to outlet end 44. In the example shown, cap 44 may be a closed cap that can be opened by an opening mechanism, including a diaphragm or other weakened area (not shown). In this example, carriage 64 may include an opening pin 62 configured to pierce or preferentially tear the diaphragm, as described elsewhere herein. Additional information regarding usable cans and methods of manufacture thereof can be found in U.S. Publication No. 2017 / 0258583, the entire disclosure of which is expressly incorporated herein by reference.
[0055] Alternatively, cap 44 may include other closure mechanisms (such as a ball or other component (not shown)) that may be biased or otherwise configured to close the outlet in cap 44, but may be guided away from cap 44 by carriage 64, for example, into canister 40, to open the outlet and release pressurized gas within chamber 48. In this alternative, opening pin 62 may include a tapered end (not shown) sized to enter the outlet and push the cap away from the outlet.
[0056] The plunger 50 may be an elongated rod or other component, including a proximal end 52 slidably disposed within the second chamber 24 (e.g., initially adjacent to the first chamber 22) and a distal end 54 coupled to the piston 74. The plunger 50 may be moved from an initial or retracted position (e.g., as shown in Figures 2A and 2B) to a final or extended position (e.g., Figure 6A and Figure 6B As shown in the figure, for example, the distal end 54 extends from the second end 16 of the drive assembly 12 into the drug chamber 73 of the syringe 70.
[0057] A flange or other guide member 53 that slidably engages the wall of the second chamber 24 may be provided on the proximal end 52 of the plunger 50. Thus, when pressurized gas (via the first chamber 22) enters the second chamber 24, the pressure generates a distal force to guide the plunger 50 distally from its initial position toward its extended position, thereby advancing the piston 74 and delivering one or more medications from the medication chamber 73 through the needle 78 to the subject, as further described elsewhere herein.
[0058] Optionally, a wall, orifice, or intermediate channel (not shown) may be provided between the first chamber 22 and the second chamber 24. The intermediate channel may have a relatively small diameter to provide a limiter to reduce the pressure rise time within the second chamber 24. For example, the intermediate channel may: i) slow the transient flow of gas, thereby slowing the pressure rise applied to the plunger 50, for example providing a soft start for injection, reducing / eliminating pressure shock waves in the fluid to be injected into the syringe, and reducing patient pain when drug injection is gently initiated; and / or ii) slow the steady-state flow of gas, thereby reducing the pressure that would otherwise be applied to the plunger 50, providing a limiting effect on the flow rate of the drug injected into the patient.
[0059] Optionally, as shown, the plunger 50 may also include, for example, a plunger chamber 56 extending from the proximal end 52 of the plunger 50 to the closed distal end 54. The plunger chamber 56 may taper inward from the proximal end 52 to the distal end 54 (as shown), or may have a uniform diameter or other cross-sectional shape along its length. Alternatively, the proximal end 52 of the plunger 50 may include a closing wall and / or the plunger 50 may be a solid rod between the proximal end 52 and the distal end 54.
[0060] Optionally, the flange 53 on the proximal end 52 of the plunger 50 may include one or more channels (not shown) extending between the proximal and distal surfaces of the flange 53. For example, the flange 53 may include a plurality of circular or other closed channels spaced apart from each other around the circumference of the flange 53, each channel extending between the proximal and distal surfaces.
[0061] In this option, the flange 53 may be sized and / or shaped to slidably engage the inner wall of the second chamber 24, for example, to allow the plunger 50 to move from an initial position to an extended position, but may not require O-rings or other seals. Alternatively, one or more O-rings or other seals may be provided within and / or near the inner housing 20 to seal the first chamber 22 and the second chamber 24 and / or otherwise seal the flow path from the gas canister 40 to the plunger 50. For example, a first O-ring 58a may be provided between the inner housing 20 and the carriage 64, a second O-ring 58b may be provided between the distal end 21b of the inner housing 20 and the plunger 50, and / or a third O-ring 58c may be provided between the proximal cylinder 10a and the distal cylinder 10b if they are configured as separate components fixed together.
[0062] In one example, plunger 50 includes a flange 53 formed as a cylindrical head with an outer diameter larger than that of plunger 50. Flange 53 may be integrally molded with or otherwise formed with plunger 50, or manufactured separately and permanently attached to plunger 50. One or more channels (not shown) extend between the proximal and distal surfaces of flange 53. When canister 40 is opened to release pressurized gas, the initial volume that the gas needs to fill includes a first chamber 22 surrounding canister 40, a second chamber 24 surrounding plunger 50, and an optional plunger chamber 56. Gas filling the available volume may result in an initial pressure drop. However, as plunger 50 advances, the volume that the gas needs to fill increases only slightly (e.g., the volume occupied by plunger 50 within the second chamber 24, which is displaced from the distal end 16 of drive assembly 12). Therefore, because the volume change is minimized, the force exerted on plunger 50 by pressure can remain substantially constant or decrease only slightly. Therefore, the decrease in force applied to plunger 50 can be minimized, which allows for a more uniform delivery rate of the drug from syringe 70. Additional information regarding plungers that can provide reduced pressure drop can be found in co-pending U.S. Application Serial No. 17 / 965,707, the entire disclosure of which is expressly incorporated herein by reference.
[0063] Optionally, the proximal end 52 of the plunger 50 may have a larger diameter or other cross-section than the distal end 54 of the plunger 50. For example, the outer diameter or cross-section may taper between the proximal end 52 and the distal end 54 of the plunger 50. This tapered shape increases the cross-sectional area of the plunger 50 as it advances from the initial position to the extended position, which minimizes the variation in the distal force applied to the syringe stopper due to volume changes, potentially useful for applications requiring a constant delivery rate. It should be understood that any of these optional features associated with the plunger 50 may be combined or omitted as needed.
[0064] Turning to Figures 2A and 2B, the opening mechanism 60 includes a release cap 34 and a spring seat assembly or carriage 64 slidably coupled to the rear housing 12 (e.g., located within the second region 22b and third region 22c of the first chamber 24). The carriage 64 carries an opening pin 62, for example, mounted along axis 18 and oriented toward the distal cap 44. The carriage 64 and the release cap 34 include one or more features that disengage when the release cap 34 is guided proximally (by the actuation cap 80 and spacer 30), and the carriage 64 can be biased to move distally upon release, thereby guiding the opening pin distally to open the outlet in the cap 44 of the can 40.
[0065] For example, the rear housing 12 and the carriage 64 may include mating features that prevent the carriage 64 from moving before the device 6 is activated. For example, as in Figures 5A-5CAs most clearly shown, the carriage 64 includes a locking tab or other feature 64a at its proximal end that engages the proximal end 13a of the rear housing 12, and a flange 64b at its distal end that is slidable within a second region 22b of the first chamber 24. A puncture spring 66 is also disposed within the second region 22b around the carriage 64, for example, a helical spring disposed in an initially compressed state between the rear housing 12 and the flange 64b. Thus, the spring 66 biases the carriage 64 to move distally, but is constrained by the engagement of the locking feature 64a with the proximal end 13a of the rear housing 12.
[0066] The release cap 34 and the carriage 64 include mating features that release the locking feature 64a from the rear housing 12 when the device 6 is activated. For example, as Figures 5A-5C As shown, the release cap 34 includes a cylindrical body surrounding a portion of the rear housing 12, for example, surrounding the second region 22b and the third region 22c of the first chamber 24. The release cap 34 may also include a closed proximal end 34a near the proximal end 13a of the rear housing 12 and a distal end 34b, the distal end 34b including one or more features that restrict axial movement of the release cap 34. For example, one or more flanges on the distal end 34b may slide proximally along the inner surface of the housing 8, for example, until they abut against a ridge on the housing 8 to prevent further proximal movement of the release cap 34, as further described elsewhere herein.
[0067] As shown, a central hub 36 is disposed on the proximal end 34a of the release cap 34, aligned distally toward the opening pin 62 along axis 18. The carriage 64 includes a plurality of tabs or release fingers 65, arranged concentrically about axis 18, such that the tabs 65 can slide along the hub 36 when the release cap 34 is guided proximally. Once the hub 36 moves proximally past the tabs 65, the tabs 65 are biased to move radially inward (towards the central axis 18), thereby guiding the locking feature 64a inward. Once the locking feature 64a disengages from the proximal end 13a of the rear housing 12, for example, as... Figure 5C As shown, the spring 66 can automatically guide the carriage 64 to the distal end, thereby guiding the opening pin 62 to the distal end to pierce the diaphragm in the cap 44 of the can 40 (or otherwise open the outlet).
[0068] During use, the device 6 may initially be equipped with a safety cap 86 attached to the distal end 8b of the outer casing 8, for example, as Figure 1 - As shown in Figure 2B. Just before injection, the safety cap 86 can be removed, for example, by simply pulling the safety cap 86 distally away from the outer shell 8 to expose the contact surface 84 of the activation cap 80, for example, as... Figure 4A As shown. For example, as Figure 3A and Figure 3BMost clearly shown, the helmet 86 may include an inner cylindrical member and an outer cylindrical member, the proximal end 86a of the inner member being coupled to the needle guard 79, and the proximal end 86b of the outer member being slidably received on the distal end 8b of the outer shell 8. Alternatively, the helmet 86 and / or the outer shell 8 may include one or more connectors, locks, etc. (not shown) that can be disengaged before the helmet 86 is removed.
[0069] As described elsewhere herein, the safety cap 86 prevents the activation cap 80 from being guided proximally, for example, by preventing the activation cap 80 from being contacted. Additionally or alternatively, the safety cap 86 may include features that engage the needle shield 79 such that when the safety cap 86 is removed, the needle shield 79 is also removed. The safety cap 86 and the needle shield 79 prevent the needle 78 from being exposed from the housing 8 before use. Once the safety cap 86 and the needle shield 79 are removed, the device 6 is ready for injection.
[0070] Go to Figures 4A-4C The contact surface 84 can be placed against the subject's skin (not shown), and then the device 6 can be pressed against the skin to insert the needle 78, so that when the needle 78 enters the subject's skin, the activation cap 80 is released. Figure 4A The initial position shown is slid proximally to Figure 4B The retracted position is shown. As further described below, this action activates the opening mechanism 60, causing the opening pin 62 to open the outlet of the gas canister 40 to release pressurized gas into the first chamber 22. The pressurized gas then advances the plunger 50, and thus the piston 74, to deliver the drug into the subject through the needle 78.
[0071] For example, such as Figure 4A As shown, in the initial state, the proximal end 82 of the activating cap 80 can abut or otherwise engage the distal end 30a of the spacer 30, and the proximal end 30b of the spacer 30 can abut or otherwise engage the distal end 34b of the release cap 34. Therefore, when the activating cap 80 retracts proximally within the housing 8, its proximal end 82 pushes the distal end 30a of the spacer 30, thereby guiding the spacer 30 proximally, and the proximal end 30b of the spacer 30 in turn pushes the distal end 34b of the release cap 34, thereby guiding the release cap 34 proximally, for example, until the proximal end 34a of the release cap 34 contacts the proximal end 8c of the housing 8.
[0072] As the start cap 80, spacer 30, and release cap 34 move proximally, the inner housing 20 (and the canister 40 within the first chamber 22) remain substantially fixed. Figure 4A and Figure 4BAs can be seen, when the spacer 30 is guided proximally, the spring 32 can be compressed, for example, between the feature on the distal end 30a of the spacer 30 and the inner housing 20, thereby biasing the spacer 30 to move distally. However, the spacer 30 cannot move distally because the operator presses the contact surface 84 of the activation cap 80 against the subject's skin.
[0073] Since the carriage 64 is fixed relative to the inner housing 20 by the locking feature 64a, the carriage 64 also remains substantially fixed, causing the release cap 34 to move proximally relative to the carriage 64, and the tab 65 on the carriage 64 slides along the hub 36 on the release cap 34, as... Figures 5A-5C As shown most clearly. When the release cap 34 reaches its nearest side position, for example, as Figure 4C and Figure 5C As shown, hub 36 has moved proximally past the end of tab 65, and tab 65 is released and automatically moves inward when it is biased inward. Since tab 65 is connected to locking feature 64a on carriage 64, the inward movement of tab 65 causes locking feature 64a to move inward, thereby disengaging locking feature 64a from proximity end 21a of inner housing 20.
[0074] Due to spring 66, slide 64 is subsequently released and biased to move distally, thereby advancing opening pin 62 distally to open the outlet of can 40, as... Figure 4C and Figure 5C As shown. The release cap 34 may include one or more tabs or other features 34c, for example, corresponding to recesses 8d in the housing 8, such that when the release cap 34 reaches its farthest position, the tabs 34c are received in the corresponding recesses 8d, as shown. Therefore, when the carriage 64 is advanced distally by the spring 66, the tabs 34c prevent the release cap 34 from moving distally.
[0075] As the carriage 64 moves distally, it causes the opening pin 62 to advance and pierce the diaphragm in the cap 44 (or otherwise open the outlet), thereby releasing the pressurized gas within the canister 40. The released pressurized gas then enters the first chamber 22, for example, around the canister 40, and is transferred to the second chamber 24, thereby pressurizing the second chamber 24 to generate a distal force, thereby guiding the plunger 50 distally from its initial position toward its extended position to deliver one or more medications from the syringe 70 through the needle 78 into the subject, for example, as... Figure 6A As shown.
[0076] During injection, the operator can monitor the syringe 70, for example through window 8c, to confirm that the piston 74 has been fully advanced distally within the syringe 72, thereby delivering the full dose to the subject. Once the injection is complete, the device 6 can be guided away from the subject, thereby withdrawing the needle 78 from the subject's skin. As the device 6 is guided away from the subject's skin, the activation cap 80 moves freely distally, and due to the distal bias of the spring 32, the spacer 30 automatically advances distally, thereby guiding the activation cap 80 distally to cover the needle 78 as it retracts.
[0077] like Figure 6C Most clearly shown, as the spacer 30 advances distally, the proximal end 30b of the spacer can distally pass over the feature 34d on the distal end 34b of the release cap 34. For example, the feature 34b may include one or more fingers or tabs that slide along the interior of the spacer 30 until the proximal end 30b passes distally, whereby the tabs can resiliently move radially outward, for example, such that the tab 34d is located proximal to the proximal end 30b of the spacer 30, thereby preventing subsequent movement of the spacer 30 proximal to the proximal end. With the spacer 30 prevented from moving proximal, the activation cap 80 cannot retract again, thus locking the activation cap 80 to extend above the needle 78 and preventing accidental exposure of the needle 78.
[0078] If device 6 is a disposable device, it can be discarded. If the device is reusable, for example, if the front housing 10 and the rear housing 12 are separable, the rear housing 12 can subsequently be separated from the front housing 10, and the syringe 70 can be removed. For reusable devices, one or more features may be provided within the device to release any residual pressure in the first chamber 22 and the second chamber 24. For example, as... Figure 6A and Figure 6B As shown, a valve and / or shaft assembly may be provided within the plunger 50, which can be actuated to release pressurized gas before disengaging the plunger 50 from the piston 74. The separated housings 10, 12 can then be cleaned and / or sterilized, and a new gas canister 40 can be loaded into the inner housing 20 before reassembling the device.
[0079] Go to Figure 7A An exemplary injection device 6 is shown (e.g., similar to...). Figure 1- A cross-sectional detail of the device 6 shown in Figure 6, with some components omitted for clarity. As previously described, the gas canister 40 and the opening mechanism 60 occupy a significant amount of space within the drive module 12 of the injection device 6. In particular, as shown, the canister 40 and the opening mechanism 60 are axially mounted within the inner housing 20 near the plunger 50, thus defining the minimum axial length of the drive module 12, which is the sum of the lengths of the plunger 50, the canister 40, and the opening mechanism 60 along axis 18.
[0080] Similarly, Figure 7B An alternative example of the injection device 6' is shown, wherein the gas cylinder 40 is positioned distally rather than as shown. Figure 7A The orientation is shown to the proximal side. In this alternative, the opening mechanism is omitted, but it must occupy some space between the can 40 and the plunger 50. Therefore, the device 6' has a minimum axial length based on the lengths of the plunger 50', the opening mechanism, and the can 40.
[0081] Generally, the plungers 50, 50' (also referred to herein as "force-providing components" because they exert a distal force on the piston 74 of the syringe 70) are the longest components of the drive module 12, their length corresponding to the length of the syringe 70 to ensure delivery of the full dose of medication contained in the medication chamber 73 of the syringe 70. Given this length, the second chamber 24 within the inner housing 20 (which initially houses the plungers 50) will have a corresponding length and volume. Therefore, the canister 40 must have sufficient pressurized gas volume and pressure to fill the first chamber 22 surrounding the canister 40, as well as the second chamber 24 and any internal plunger chamber 56, while providing the desired distal force to the plungers 50 to advance the piston 74.
[0082] Therefore, it would be useful to provide an injection device that shortens the total length, thereby providing a more compact injection device that is easy to operate and use, and / or reduces the total volume that must be filled by pressurized gas from a gas cylinder.
[0083] For example, go to Figure 8A and Figure 8B An example of an injection device 106 is shown, which includes a drive module 112 comprising an inner housing 120 and a plunger 150 slidably disposed within a housing chamber 124. Device 106 may include other components similar to those of device 6 (e.g., housing, actuator, etc.), which are omitted for clarity. Unlike device 6, a canister 40 and an opening mechanism 160 are provided, nested within the inner plunger chamber 156 of the plunger 150. Therefore, when the plunger 150 is in its proximal or initial position ( Figure 8A ) Towards the distal or extended portion of the plunger ( Figure 8BDuring advancement, the can 40 and the opening mechanism 160 can remain substantially fixed relative to the plunger 150, that is, move axially relative to the inner housing 120 together with the plunger 150.
[0084] Although the inner housing 120 is shown as... Figure 7A The inner housing 12 shown is equivalent, but it should be understood that the proximal region 122 within the inner housing 120 (similar to the first chamber 22 in device 6) can be omitted in device 106, which can significantly shorten the axial length of the drive module 112, for example, according to Figure 8A The length is shortened by the amount L shown. If the proximal region 122 is omitted, the total volume of the drive module 112 exposed to pressurized gas can also be significantly reduced.
[0085] For example, as shown, a can 40 may be mounted within a plunger chamber 156, with the can's cap 44 and outlet oriented proximally away from the plunger 150. The can 40 may be secured within a seat within the plunger chamber 156, such that the can 40 is fixed relative to the plunger 150. An opening mechanism 160 may be disposed within the plunger chamber 156 proximally to the can cap 44 and may include a spring seat assembly or carriage 164 carrying an opening pin 162 initially spaced apart from the outlet of the cap 44, for example, similar to the previously described device.
[0086] For example, the carriage 164 may be biased distally, for example by a spring 166 or other biasing mechanism, but may be initially locked relative to the plunger 150, for example, using features similar to those of the previously described device 6. The device 160 may also include an actuator (not shown), for example, an actuation cap and / or spacer (not shown) surrounding the syringe 70 and / or inner housing 120, which may be actuated when the device 160 is pressed against the patient's skin to insert the needle 78 to perform an injection. The actuator may release the carriage 164, which in turn may displace the carriage 164 and thus displace the opening pin 162 to open the diaphragm or other outlet in the cap 44 of the canister 40. Alternatively, a manual actuator (such as a button or dial (not shown)) may be provided on the drive module 120, which may be operatively coupled to the carriage 164 to release the carriage 164 and guide the opening pin 162 to open the outlet when actuated by a user.
[0087] Once the outlet of canister 40 is opened, the pressurized gas within canister 40 can then be released and enters the plunger chamber 156 and the chamber 124 within the inner housing 120, thereby applying a distal force to the plunger 150 to guide it distally and thus guide the piston 74, thereby delivering the medication within the syringe chamber 73, similar to other devices described herein. With canister 40 and opening mechanism 160 nested within the plunger 150, the canister and opening mechanism 160 travel distally together with the plunger 150, as... Figure 8BAs shown. Therefore, although the carriage 164 of the opening mechanism 160 can initially move within the plunger 150 to guide the opening pin 162 to open the can outlet, the carriage 164 can subsequently remain substantially fixed relative to the plunger 150.
[0088] Alternatively, if desired, the operation of can 40 and carriage 164 can be reversed; that is, can 40 can be mounted within plunger chamber 156 such that when the device is activated, can 40 can be moved axially to open the outlet via an opening pin on a fixed opening mechanism. Subsequently, in this alternative, the can can remain fixed and move distally with plunger 150.
[0089] It should be understood that the volume that must be filled by pressurized gas from tank 40 may only need to fill the remaining volume of plunger chamber 156 around and / or distal to tank 40, and chamber 124 within inner shell 120 located proximal to the plunger 150 as the plunger moves distally. Therefore, with Figure 7A Compared to the device 6 shown, the volume and / or pressure of the gas in the tank 40 can be reduced (while providing the same desired distal force) because the region 122 corresponding to the length reduction L can be omitted from the device 106.
[0090] Go to Figure 9A and Figure 9B Another example of an injection device 206 is shown, which includes a syringe 70 and a drive module 212. The drive module includes an inner housing 220 (and may include other components, such as an outer housing, actuators, etc., similar to the previous device, which are omitted for clarity). Unlike the previous device, device 206 includes a combined plunger / canister 250, which includes a proximal end 252, a distal end 254, and an internal plunger chamber 256. The distal end is operatively coupled to the piston 74 of the syringe 70. An outlet 258 may be located on the proximal end 252, for example, including a diaphragm or other closure (not shown), which is initially closed but can be opened by an opening mechanism 266 (not shown). For example, the opening mechanism may include a carriage carrying an opening pin (not shown), which may be initially spaced from the outlet 258, and when device 206 is activated, the opening pin may be axially displaced to open the outlet 258 and release pressurized gas within the plunger chamber 256, similar to the previous device.
[0091] Once outlet 258 is opened, pressurized gas can fill chamber 224 within inner housing 220, thereby applying distal force to guide plunger 250 distally and thus piston 74 distally, thereby delivering the medication in syringe chamber 73 into the patient through needle 78.
[0092] Similarly, it should be understood that the proximal region of the inner housing 220 can be reduced by a length reduction L, which can shorten the overall length of the device 206 and / or reduce the volume of pressurized gas required to fully advance the plunger 250.
[0093] While the invention is readily adaptable to various modifications and alternatives, specific examples have been shown in the accompanying drawings and described in detail herein. However, it should be understood that the invention is not limited to the particular forms or methods disclosed, but rather is intended to cover all modifications, equivalents, and alternatives falling within the scope of the appended claims.
Claims
1. A drive module for delivering one or more pharmaceutical agents from an injection device module into a patient, the injection device module including a drug chamber containing one or more pharmaceutical agents, an outlet, and a piston, the drive module comprising: A drive housing, the drive housing including a first end and a second end and a first chamber located in the drive housing; A plunger, the plunger including a proximal end disposed in the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger being configured to be coupled to the piston of the injection device module; A canister, at least partially received in the plunger such that the canister follows the movement of the plunger, the canister containing pressurized gas and including an outlet; An opening mechanism, located within the drive housing and including an actuating pin disposed adjacent to the outlet; and An actuator configured to move one of the opening mechanism and the canister to cause the actuation pin to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger and the canister, the plunger being configured to advance the piston of the injection device module to deliver the one or more medications from the medication chamber.
2. The drive module of claim 1, wherein the plunger includes a plunger chamber extending between the proximal end and the distal end, and wherein the canister is mounted in the plunger chamber.
3. The drive module of claim 2, wherein the plunger chamber is opened at the proximal end such that pressurized gas released from the canister enters the first chamber from the plunger chamber, and wherein the plunger chamber is closed at the distal end such that the released pressurized gas exerts a distal force on the plunger to guide the plunger from the initial position to the extended position.
4. The drive module of claim 2, wherein the opening mechanism is installed in the plunger chamber adjacent to the outlet.
5. The drive module of claim 4, wherein the opening mechanism includes a carriage carrying an opening pin spaced apart from the outlet, the actuator being configured to release the carriage upon activation, thereby displacing the carriage within the plunger chamber to open the outlet.
6. The drive module of claim 5, wherein the opening mechanism further includes a release cap operably coupled to the actuator, such that when the actuator is activated, the release cap is displaced relative to the plunger to release the carriage, and subsequently, the carriage is displaced in the plunger chamber to open the outlet.
7. The drive module of claim 6, further comprising a locking element for securing the carriage within the plunger chamber, wherein when the release cap is displaced, the locking element releases the carriage, which is biased to move toward the can such that the opening pin opens the outlet.
8. The drive module of claim 4, wherein the tank includes a diaphragm that closes the outlet, and wherein the opening pin is configured to tear or puncture the diaphragm to open the outlet when the carriage is displaced in the plunger chamber.
9. The drive module of any one of claims 2 to 8, wherein the can is axially fixed relative to the plunger, such that the can moves distally together with the plunger.
10. The drive module of claim 9, wherein the carriage is mounted in the plunger chamber such that after an initial displacement to open the outlet, the carriage moves distally together with the plunger.
11. The drive module of any one of claims 1 to 8, wherein the actuator includes an actuating sleeve configured to retract when the injection device module is pressed against the patient's skin, the actuating sleeve being operatively coupled to the opening mechanism to release the opening mechanism, thereby causing the actuating pin to open the outlet.
12. The drive module of any one of claims 1 to 8, wherein the actuator includes a manual actuator configured to be manually activated by a user to actuate the opening mechanism to open the outlet.
13. The apparatus of claim 12, wherein the manual actuator comprises one of a screw, a button, and a lever.
14. A drive module for delivering one or more pharmaceutical agents from an injection device module into a patient, the injection device module including a drug chamber containing one or more pharmaceutical agents, an outlet, and a piston, the drive module comprising: A drive housing, the drive housing including a first end and a second end and a first chamber located in the drive housing; A plunger, the plunger including a proximal end disposed in the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger being configured to be coupled to the piston of the injection device module; A plunger chamber located within the plunger and containing pressurized gas, and including an outlet adjacent to the proximal end; An opening mechanism, located within the drive housing and including an actuating pin disposed adjacent to the outlet; and An actuator configured to move one of the opening mechanism and the canister to cause the actuating pin to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger, the plunger being configured to advance the piston of the injection device module to deliver the one or more medications from the medication chamber.
15. The drive module of claim 14, wherein the opening mechanism is mounted in the first chamber near the proximal end of the plunger.
16. The drive module of claim 15, wherein the opening mechanism includes a carriage carrying an opening pin spaced apart from the outlet, the actuator being configured to release the carriage upon activation, thereby displacing the carriage within the plunger chamber to open the outlet.
17. The drive module of claim 16, wherein the opening mechanism further includes a release cap operably coupled to the actuator such that when the actuator is activated, the release cap is displaced relative to the plunger to release the carriage, and subsequently, the carriage is displaced in the plunger chamber to open the outlet.
18. The drive module of claim 16, further comprising a locking element securing the carriage within the plunger chamber, wherein when the release cap is displaced, the locking element releases the carriage, which is biased to move toward the can such that the opening pin opens the outlet.
19. The drive module of any one of claims 14 to 18, wherein the plunger includes a diaphragm that closes the outlet, and wherein the opening pin is configured to tear or puncture the diaphragm to open the outlet.
20. The drive module of any one of claims 14 to 18, wherein the actuator includes an actuating sleeve configured to retract when the injection device module is pressed against the patient's skin, the actuating sleeve being operatively coupled to the opening mechanism to release the opening mechanism, thereby causing the actuating pin to open the outlet.
21. The drive module of any one of claims 14 to 18, wherein the actuator includes a manual actuator configured to be manually activated by a user to actuate the opening mechanism to open the outlet.
22. A device for delivering one or more pharmaceutical agents into a patient, comprising: a) An injection device module, the injection device module comprising an injection device housing and a piston, the injection device housing carrying a drug chamber for containing one or more drugs, the piston being slidably disposed within the drug chamber; and b) A driver module, the driver module comprising: A drive housing, the drive housing including a first end and a second end and a first chamber located in the drive housing; A plunger, the plunger including a proximal end disposed in the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger being coupled to the piston of the injection device module; A canister, at least partially received in the plunger such that the canister follows the movement of the plunger, the canister containing pressurized gas and including an outlet; An opening mechanism, located within the drive housing and including an actuating pin disposed adjacent to the diaphragm; and An actuator configured to move one of the opening mechanism and the canister to cause the actuating pin to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger and the canister, wherein the plunger advances the piston of the injection device module to deliver the one or more medications from the medication chamber.
23. The apparatus of claim 22, wherein the injection device module is connectable to the second end of the drive housing.
24. The apparatus of claim 22, wherein the injection device module comprises a syringe.
25. The apparatus of claim 22, wherein the injection device module and the drive module are integrally housed within the housing.
26. The apparatus of claim 22, wherein the plunger includes a plunger chamber extending between the proximal end and the distal end, and wherein the canister is mounted in the plunger chamber.
27. The apparatus of claim 22, wherein the plunger chamber is opened at the proximal end such that pressurized gas released from the canister enters the first chamber from the plunger chamber, and wherein the plunger chamber is closed at the distal end such that the released pressurized gas exerts a distal force on the plunger to guide the plunger from the initial position to the extended position.
28. The apparatus of claim 22, wherein the opening mechanism is mounted in the plunger chamber adjacent to the outlet.
29. The apparatus of claim 28, wherein the opening mechanism includes a carriage carrying an opening pin spaced apart from the outlet, the actuator being configured to release the carriage upon activation, thereby displacing the carriage in the plunger chamber to open the outlet.
30. The apparatus of claim 29, wherein the opening mechanism further includes a release cap operably coupled to the actuator such that when the actuator is activated, the release cap is displaced relative to the plunger to release the carriage, and subsequently, the carriage is displaced in the plunger chamber to open the outlet.
31. The apparatus of claim 30, further comprising a locking element securing the carriage within the plunger chamber, wherein when the release cap is displaced, the locking element releases the carriage, which is biased to move toward the can such that the opening pin opens the outlet.
32. The apparatus of claim 29, wherein the can includes a diaphragm that closes the outlet, and wherein the opening pin is configured to tear or puncture the diaphragm to open the outlet when the carriage is displaced in the plunger chamber.
33. The apparatus of any one of claims 22 to 32, wherein the can is axially fixed relative to the plunger such that the can moves distally together with the plunger.
34. The apparatus of claim 33, wherein the carriage is mounted in the plunger chamber such that after an initial displacement to open the outlet, the carriage moves distally together with the plunger.
35. The device of any one of claims 22 to 32, wherein the actuator includes an actuating sleeve configured to retract when the injection device housing is pressed against the patient's skin to insert a needle into the injection device module, the actuating sleeve being configured to release the opening mechanism to allow the actuating pin to open the outlet and release the pressurized gas.
36. The apparatus of any one of claims 22 to 32, wherein the actuator includes a manual actuator located on the drive module, the manual actuator being manually activated by a user to actuate the opening mechanism to open the diaphragm and release the pressurized gas.
37. The apparatus of claim 36, wherein the manual actuator comprises one of a screw, a button, and a lever.
38. A device for delivering one or more pharmaceutical agents into a patient, comprising: a) An injection device module, the injection device module comprising an injection device housing and a piston, the injection device housing carrying a drug chamber for containing one or more drugs, the piston being slidably disposed within the drug chamber; and b) A driver module, the driver module comprising: A drive housing, the drive housing including a first end and a second end and a first chamber located in the drive housing; A plunger, the plunger including a proximal end disposed in the first chamber and slidable from an initial position to an extended position, in which a distal end of the plunger extends from the second end of the drive housing, the distal end of the plunger being coupled to the piston of the injection device module; A plunger chamber located within the plunger and containing pressurized gas, and including an outlet adjacent to the proximal end; An opening mechanism, located within the drive housing and including an actuating pin disposed adjacent to the outlet; and An actuator configured to move one of the opening mechanism and the canister to cause the actuating pin to open the outlet and allow gas from the canister to flow into the first chamber to advance the plunger, the plunger being configured to advance the piston of the injection device module to deliver the one or more medications from the medication chamber.
39. The apparatus of claim 38, wherein the opening mechanism is mounted in the first chamber adjacent to the proximal end of the plunger.
40. The apparatus of claim 39, wherein the opening mechanism includes a carriage carrying an opening pin spaced apart from the outlet, the actuator being configured to release the carriage upon activation, thereby displacing the carriage within the plunger chamber to open the outlet.
41. The apparatus of claim 40, wherein the opening mechanism further includes a release cap operably coupled to the actuator such that when the actuator is activated, the release cap is displaced relative to the plunger to release the carriage, and subsequently, the carriage is displaced in the plunger chamber to open the outlet.
42. The apparatus of claim 40, further comprising a locking element securing the carriage within the plunger chamber, wherein when the release cap is displaced, the locking element releases the carriage, which is biased to move toward the can such that the opening pin opens the outlet.
43. The apparatus of any one of claims 38 to 42, wherein the plunger includes a diaphragm that closes the outlet, and wherein the opening pin is configured to tear or puncture the diaphragm to open the outlet.
44. The device of any one of claims 38 to 42, wherein the actuator includes an actuating sleeve configured to retract when the injection device module is pressed against the patient's skin, the actuating sleeve being operatively coupled to the opening mechanism to release the opening mechanism, thereby causing the actuating pin to open the outlet.
45. The apparatus of any one of claims 38 to 42, wherein the actuator includes a manual actuator configured to be manually activated by a user to actuate the opening mechanism to open the outlet.
46. The apparatus of claim 45, wherein the manual actuator comprises one of a screw, a button, and a lever.
Citation Information
Patent Citations
Self-powered syringe drivers
US10716892B2
Gas-powered fluid injection system
US10912883B2
Injection devices and methods for making and using them
US11071824B2
Gas canisters and methods for making them
US20170258583A1
Drive modules for injectors, and systems and methods for using such drive modules
US20230119081A1
